Riverhead Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-12,563
| Closed | -$79K | – | 1587 |
|
|
2018
Q3 | $79K | Buy |
12,563
+900
| +8% | +$5.66K | ﹤0.01% | 1436 |
|
|
2018
Q2 | $94K | Hold |
11,663
| – | – | ﹤0.01% | 1357 |
|
|
2018
Q1 | $87K | Buy |
11,663
+2,700
| +30% | +$20.1K | ﹤0.01% | 1377 |
|
|
2017
Q4 | $53K | Buy |
8,963
+2,200
| +33% | +$13K | ﹤0.01% | 1468 |
|
|
2017
Q3 | $50K | Buy |
6,763
+1,640
| +32% | +$12.1K | ﹤0.01% | 1446 |
|
|
2017
Q2 | $35K | Buy |
5,123
+2,723
| +113% | +$18.6K | ﹤0.01% | 1471 |
|
|
2017
Q1 | $23K | Buy |
+2,400
| New | +$23K | ﹤0.01% | 1448 |
|